A Phase II Evaluation of Lapatinib in the Treatment of Persistent or Recurrent Epithelial Ovarian or Primary Peritoneal Carcinoma: A Gynecologic Oncology Group Study
Gynecologic Oncology - United States
doi 10.1016/j.ygyno.2011.10.022
Full Text
Open PDFAbstract
Available in full text
Date
March 1, 2012
Authors
Publisher
Elsevier BV